Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RFPL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
ERH - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RBM5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FAF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EBLN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRMT2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
ELOVL6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SGPL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMCO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PCDHA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC100289518 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DUS4L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WISP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SEC24A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SNRPC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GDE1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLRC4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KCNJ4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on